EP2224806A4 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: EP2224806A4
Authority: EP; European Patent Office
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2007-12-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08862226.1A

Other languages

German (de)

French (fr)

Other versions

EP2224806A1 (en

Inventor

Alfred Liang

Frank Matthews

Garth Boehm

Lijuan Tang

Frank Johnson

Joseph Stauffer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alpharma Pharmaceuticals LLC

Original Assignee

Alpharma Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-17

Filing date

2008-12-16

Publication date

2014-02-19

2008-12-16 Application filed by Alpharma Pharmaceuticals LLC filed Critical Alpharma Pharmaceuticals LLC

2010-09-08 Publication of EP2224806A1 publication Critical patent/EP2224806A1/en

2014-02-19 Publication of EP2224806A4 publication Critical patent/EP2224806A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine

EP08862226.1A 2007-12-17 2008-12-16 Pharmaceutical composition Withdrawn EP2224806A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US788207P	2007-12-17	2007-12-17
PCT/US2008/087030 WO2009079518A1 (en)	2007-12-17	2008-12-16	Pharmaceutical composition

Publications (2)

Publication Number	Publication Date
EP2224806A1 EP2224806A1 (en)	2010-09-08
EP2224806A4 true EP2224806A4 (en)	2014-02-19

Family

ID=40795902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08862226.1A Withdrawn EP2224806A4 (en)	2007-12-17	2008-12-16	Pharmaceutical composition

Country Status (4)

Country	Link
EP (1)	EP2224806A4 (en)
AU (1)	AU2008338439A1 (en)
CA (1)	CA2709903A1 (en)
WO (1)	WO2009079518A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1299104T3 (en)	2000-02-08	2009-08-03	Euro Celtique Sa	Oral opioid agonist formulations secured against forgery
MY135852A (en)	2003-04-21	2008-07-31	Euro Celtique Sa	Pharmaceutical products
WO2009085778A1 (en) *	2007-12-17	2009-07-09	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
CA2709992A1 (en) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Abuse resistant pharmaceutical compositions of opiod agonists

Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997033566A2 (en) *	1996-03-12	1997-09-18	Alza Corporation	Composition and dosage form comprising opioid antagonist
WO2001058451A1 (en) *	2000-02-08	2001-08-16	Euro-Celtique, S.A.	Tamper-resistant oral opioid agonist formulations
WO2004026283A1 (en) *	2002-09-20	2004-04-01	Alpharma, Inc.	Sequestering subunit and related compositions and metohds
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
US20050191244A1 (en) *	2002-10-25	2005-09-01	Gruenenthal Gmbh	Abuse-resistant pharmaceutical dosage form
US20070269505A1 (en) *	2003-12-09	2007-11-22	Flath Robert P	Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
WO2007149438A2 (en) *	2006-06-19	2007-12-27	Alpharma, Inc.	Pharmaceutical compositions
WO2008027442A2 (en) *	2006-08-30	2008-03-06	Theraquest Biosciences, Llc	Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2008063301A2 (en) *	2006-10-11	2008-05-29	Alpharma, Inc.	Pharmaceutical compositions
WO2009032270A2 (en) *	2007-09-04	2009-03-12	Alpharma, Inc.	A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
WO2009085778A1 (en) *	2007-12-17	2009-07-09	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
WO2009088673A2 (en) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8790689B2 (en) *	2003-04-30	2014-07-29	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
WO2007013975A2 (en) *	2005-07-20	2007-02-01	Pharmorx Inc.	Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications

2008
- 2008-12-16 EP EP08862226.1A patent/EP2224806A4/en not_active Withdrawn
- 2008-12-16 WO PCT/US2008/087030 patent/WO2009079518A1/en active Application Filing
- 2008-12-16 CA CA2709903A patent/CA2709903A1/en not_active Abandoned
- 2008-12-16 AU AU2008338439A patent/AU2008338439A1/en not_active Abandoned

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997033566A2 (en) *	1996-03-12	1997-09-18	Alza Corporation	Composition and dosage form comprising opioid antagonist
WO2001058451A1 (en) *	2000-02-08	2001-08-16	Euro-Celtique, S.A.	Tamper-resistant oral opioid agonist formulations
WO2004026283A1 (en) *	2002-09-20	2004-04-01	Alpharma, Inc.	Sequestering subunit and related compositions and metohds
US20050191244A1 (en) *	2002-10-25	2005-09-01	Gruenenthal Gmbh	Abuse-resistant pharmaceutical dosage form
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
US20070269505A1 (en) *	2003-12-09	2007-11-22	Flath Robert P	Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
WO2007149438A2 (en) *	2006-06-19	2007-12-27	Alpharma, Inc.	Pharmaceutical compositions
WO2008027442A2 (en) *	2006-08-30	2008-03-06	Theraquest Biosciences, Llc	Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2008063301A2 (en) *	2006-10-11	2008-05-29	Alpharma, Inc.	Pharmaceutical compositions
WO2009032270A2 (en) *	2007-09-04	2009-03-12	Alpharma, Inc.	A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
WO2009085778A1 (en) *	2007-12-17	2009-07-09	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
WO2009088673A2 (en) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOHNSON F ET AL: "(236) Relative bioavailability of plasma naltrexone from crushed ALO-01 (an investigational, abuse-deterrent, extended-release, morphine sulfate formulation with sequestered naltrexone) to a naltrexone oral solution", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, vol. 9, no. 4, 1 April 2008 (2008-04-01), pages 35, XP025871409, ISSN: 1526-5900, [retrieved on 20080401], DOI: 10.1016/J.JPAIN.2008.01.157 *
See also references of WO2009079518A1 *

Also Published As

Publication number	Publication date
AU2008338439A1 (en)	2009-06-25
CA2709903A1 (en)	2009-06-25
EP2224806A1 (en)	2010-09-08
WO2009079518A1 (en)	2009-06-25

Legal Events

Date	Code	Title	Description
2010-08-06	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2010-08-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2010-09-08	17P	Request for examination filed	Effective date: 20100624
2010-09-08	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2010-09-08	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2010-10-27	RIN1	Information on inventor provided before grant (corrected)	Inventor name: STAUFFER, JOSEPH Inventor name: JOHNSON, FRANK Inventor name: TANG, LIJUAN Inventor name: BOEHM, GARTH Inventor name: MATTHEWS, FRANK Inventor name: LIANG, ALFRED
2011-03-23	DAX	Request for extension of the european patent (deleted)
2014-02-19	A4	Supplementary search report drawn up and despatched	Effective date: 20140122
2014-02-19	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/50 20060101AFI20140116BHEP Ipc: A61K 31/485 20060101ALI20140116BHEP
2015-01-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2015-02-11	18D	Application deemed to be withdrawn	Effective date: 20140819

Publication	Publication Date	Title
HUS1800007I1 (en)	2018-03-28	Pharmaceutical composition
IL247741A0 (en)	2016-11-30	Pharmaceutical compositions
EP2133095A4 (en)	2012-09-26	Pharmaceutical composition
EP2133094A4 (en)	2010-10-13	Pharmaceutical composition
EP2191826A4 (en)	2010-09-15	Pharmaceutical composition
HK1136968A1 (en)	2010-07-16	Novel pharmaceutical composition
IL200125A0 (en)	2010-04-15	Pharmaceutical composition
EP2222313A4 (en)	2011-02-16	Pharmaceutical compositions
EP2116242A4 (en)	2013-02-13	New pharmaceutical composition
EP2224805A4 (en)	2013-10-16	Pharmaceutical composition
EP2224915A4 (en)	2014-01-22	Pharmaceutical composition
EP2146695A4 (en)	2010-05-19	Pharmaceutical compositions
HK1138774A1 (en)	2010-09-03	Pharmaceutical composition
GB0709811D0 (en)	2007-07-04	Pharmaceutical compositions
EP2224808A4 (en)	2013-11-27	Pharmaceutical composition
EP2156832A4 (en)	2010-11-24	Pharmaceutical composition
GB0707127D0 (en)	2007-05-23	Pharmaceutical compositions
EP2224806A4 (en)	2014-02-19	Pharmaceutical composition
IL205975A0 (en)	2010-11-30	Pharmaceutical composition
GB0712454D0 (en)	2007-08-08	Pharmaceutical compositions
IL205931A0 (en)	2010-11-30	Pharmaceutical composition
GB2454923B (en)	2011-04-20	Pharmaceutical compositions
IL201394A0 (en)	2010-05-31	Niacin - based pharmaceutical compositions
GB0712558D0 (en)	2007-08-08	Pharmaceutical composition
GB0717036D0 (en)	2007-10-10	Pharmaceutical composition